ALIS ASATRYAN, M.D.
Obstetrics & Gynecology Physician in BURBANK, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
ALIS ASATRYAN, M.D. reported a CMS MIPS final score of 90.815/100 — above the 83.1 national average — and filed 59 Medicare Part D claims in 2023.
- 90.815/100
- MIPS score · +8 vs avg
- 59
- Part D claims, 2023
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
ALIS ASATRYAN, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
91 Top 40% higher than 60% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
ALIS ASATRYAN, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about ALIS ASATRYAN, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in California
How Obstetrics & Gynecology Physician compares to other specialties among California providers
Obstetrics & Gynecology Physician share within California
Obstetrics & Gynecology Physician is one of the more visible NUCC categories in California
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
ALIS ASATRYAN, M.D.'s 2023 MIPS final score plotted against the Obstetrics & Gynecology Physician national average
- MIPS Final Score
- 90.815/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Obstetrics & Gynecology Physician) — 90.815/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Obstetrics & Gynecology Physician US NPIs
90.815/100 MIPS final score — 7.7 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Obstetrics & Gynecology Physician. Quality dim: 85.7976. Cost dim: 80.848.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
ALIS ASATRYAN, M.D. appears in the CMS NPPES registry as a Obstetrics & Gynecology Physician provider holding M.D. credentials at 2601 W ALAMEDA AVE STE 412, BURBANK, CA, 91505, with a listed phone of (818) 238-0120. NPI 1407240831 was issued on 03/24/2015. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ASATRYAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 59 prescription claims written by this provider, covering 28 Medicare beneficiaries and totaling roughly $6K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 90.815/100 for the 2023 performance year (Quality 85.7976, Cost 80.848), compared with the national average of 83.1.
Obstetrics & Gynecology Physician is a mid-sized specialty nationwide, with 44,313 enrolled providers across 56 states and an average of 179 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1407240831 |
|---|---|
| Specialty | Obstetrics & Gynecology Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 03/24/2015 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm ALIS ASATRYAN, M.D.'s current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where ALIS ASATRYAN, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ALIS ASATRYAN, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$66
Largest payer
Organon Llc
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — California MBC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to ALIS ASATRYAN, M.D.. To verify ALIS ASATRYAN, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 106
- Total Day Supply
- 2,963
- Generic Drug Cost
- $6K
Patient Demographics
- Average Patient Age
- 68.6 years
- Avg HCC Risk Score
- 1.20
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Estradiol | 24 |
| Clobetasol Propionate | 15 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Obstetrics & Gynecology Physician Overview
How ALIS ASATRYAN, M.D. fits within the Obstetrics & Gynecology Physician landscape nationally.
ALIS ASATRYAN, M.D.'s 59 claims are below the specialty average of 179.
Nearby Obstetrics & Gynecology Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as ASATRYAN.
Compare Obstetrics & Gynecology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore California
Frequently Asked Questions
What is ALIS ASATRYAN, M.D.'s specialty? ▼
How much does ALIS ASATRYAN, M.D. prescribe under Medicare Part D? ▼
What is ALIS ASATRYAN, M.D.'s Medicare quality score? ▼
Where is ALIS ASATRYAN, M.D. located? ▼
What is ALIS ASATRYAN, M.D.'s NPI number? ▼
How many Obstetrics & Gynecology Physician providers are there in the US? ▼
What drugs does ALIS ASATRYAN, M.D. prescribe most often? ▼
Does ALIS ASATRYAN, M.D. accept Medicare? ▼
How can I verify ALIS ASATRYAN, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology